1. Home
  2. CLLS vs HPAI Comparison

CLLS vs HPAI Comparison

Compare CLLS & HPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • HPAI
  • Stock Information
  • Founded
  • CLLS 1999
  • HPAI 2023
  • Country
  • CLLS France
  • HPAI Singapore
  • Employees
  • CLLS N/A
  • HPAI N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • HPAI
  • Sector
  • CLLS Health Care
  • HPAI
  • Exchange
  • CLLS Nasdaq
  • HPAI NYSE
  • Market Cap
  • CLLS 240.2M
  • HPAI 234.3M
  • IPO Year
  • CLLS 2007
  • HPAI N/A
  • Fundamental
  • Price
  • CLLS $1.87
  • HPAI $4.76
  • Analyst Decision
  • CLLS Buy
  • HPAI
  • Analyst Count
  • CLLS 3
  • HPAI 0
  • Target Price
  • CLLS $7.00
  • HPAI N/A
  • AVG Volume (30 Days)
  • CLLS 93.0K
  • HPAI 36.2K
  • Earning Date
  • CLLS 11-04-2024
  • HPAI 11-26-2024
  • Dividend Yield
  • CLLS N/A
  • HPAI N/A
  • EPS Growth
  • CLLS N/A
  • HPAI N/A
  • EPS
  • CLLS N/A
  • HPAI N/A
  • Revenue
  • CLLS $36,042,000.00
  • HPAI $29,575,625.00
  • Revenue This Year
  • CLLS $271.02
  • HPAI N/A
  • Revenue Next Year
  • CLLS $33.48
  • HPAI N/A
  • P/E Ratio
  • CLLS N/A
  • HPAI $23.99
  • Revenue Growth
  • CLLS 46.96
  • HPAI 132.36
  • 52 Week Low
  • CLLS $1.70
  • HPAI $3.07
  • 52 Week High
  • CLLS $3.77
  • HPAI $14.74
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 47.58
  • HPAI N/A
  • Support Level
  • CLLS $1.70
  • HPAI N/A
  • Resistance Level
  • CLLS $2.00
  • HPAI N/A
  • Average True Range (ATR)
  • CLLS 0.11
  • HPAI 0.00
  • MACD
  • CLLS 0.02
  • HPAI 0.00
  • Stochastic Oscillator
  • CLLS 56.67
  • HPAI 0.00

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About HPAI HELPORT AI LTD

Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.

Share on Social Networks: